Recent Advances in the Piperazine Based Antiviral Agents: A Remarkable Heterocycle for Antiviral Research

[1]  M. Zaki,et al.  A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products , 2023, Molecules.

[2]  E. De Clercq,et al.  Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors , 2023, Communications chemistry.

[3]  M. Nazir,et al.  Recent synthetic approaches towards thienothiophenes: a potential template for biologically active compounds. , 2023, Molecular diversity.

[4]  Yikun Wu,et al.  Trifluoromethylpyridine Piperazine Derivatives: Synthesis and Anti-plant Virus Activity. , 2023, Pest management science.

[5]  H. Pérez‐Sánchez,et al.  Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses. , 2023, Bioorganic chemistry.

[6]  Dongwei Kang,et al.  Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors , 2022, Molecules.

[7]  Dongwei Kang,et al.  Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors , 2022, Journal of medicinal chemistry.

[8]  E. De Clercq,et al.  Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators , 2022, Molecules.

[9]  Dongwei Kang,et al.  Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity , 2022, Journal of medicinal chemistry.

[10]  Waya S. Phutdhawong,et al.  2,5-Diketopiperazine Derivatives as Potential Anti-Influenza (H5N2) Agents: Synthesis, Biological Evaluation, and Molecular Docking Study , 2022, Molecules.

[11]  D. Hu,et al.  Ferulic Acid Derivatives with Piperazine Moiety as Potential Antiviral Agents. , 2022, Pest management science.

[12]  Samantha E. Zak,et al.  A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations. , 2021, RSC medicinal chemistry.

[13]  Poonam,et al.  Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach , 2021, Bioorganic & Medicinal Chemistry.

[14]  M. Fathy,et al.  In vitro inhibition and molecular docking of a new ciprofloxacin‐chalcone against SARS‐CoV‐2 main protease , 2021, Fundamental & clinical pharmacology.

[15]  Ezzat A. Hamed,et al.  Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study , 2021, Journal of Molecular Structure.

[16]  Chao Ma,et al.  Optimization and SAR research at the piperazine and phenyl rings of JNJ4796 as new anti-influenza A virus agents, part 1. , 2021, European journal of medicinal chemistry.

[17]  A. Rathore,et al.  A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus , 2021, Scientific Reports.

[18]  K. Gunasekaran,et al.  Piperazine-substituted derivatives of favipiravir for Nipah virus inhibition: What do in silico studies unravel? , 2021, SN applied sciences.

[19]  F. Steinbach,et al.  Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis , 2020, Viruses.

[20]  S. Cen,et al.  Design, synthesis and in vitro anti-influenza A virus evaluation of novel quinazoline derivatives containing S-acetamide and NH-acetamide moieties at C-4. , 2020, European journal of medicinal chemistry.

[21]  M. Uchida,et al.  Discovery of a novel 9-position modified second-generation anti-HCV candidate via bioconversion and semi-synthesis of FR901459. , 2020, Bioorganic & medicinal chemistry letters.

[22]  A. Umamaheswari,et al.  Design, synthesis, anti-tobacco mosaic viral and molecule docking simulations of urea/thiourea derivatives of 2-(piperazine-1-yl)-pyrimidine and 1-(4-Fluoro/4-Chloro phenyl)-piperazine and 1-(4-Chloro phenyl)-piperazine - A study. , 2020, Bioorganic chemistry.

[23]  S. Raghavan,et al.  Biochemical activity of RAGs is impeded by Dolutegravir, an HIV integrase inhibitor , 2020, Cell Death Discovery.

[24]  S. Cen,et al.  2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of HCV With a Novel Mechanism of Action. , 2020, Journal of medicinal chemistry.

[25]  D. E. Anderson,et al.  Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1. , 2020, Cell chemical biology.

[26]  J. McCullough,et al.  Treatment for emerging viruses: Convalescent plasma and COVID-19 , 2020, Transfusion and Apheresis Science.

[27]  E. De Clercq,et al.  Design, Synthesis, and Mechanism Study of Benzenesulfonamide-containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities. , 2020, Journal of medicinal chemistry.

[28]  E. Gallicchio,et al.  Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication. , 2020, Antiviral research.

[29]  S. Ekins,et al.  The Evolution of Pleconaril: Modified O-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy , 2020, Molecules.

[30]  A. Brancale,et al.  Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 protein. , 2020, Bioorganic & medicinal chemistry.

[31]  N. Lougiakis,et al.  Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines. , 2020, Bioorganic chemistry.

[32]  E. Novellino,et al.  Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors. , 2019, Antiviral research.

[33]  A. Brancale,et al.  A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase , 2019, Scientific Reports.

[34]  J. Sánchez-Céspedes,et al.  Optimization of piperazine-derived ureas privileged structures for effective -antiadenovirus agents. , 2019, European journal of medicinal chemistry.

[35]  E. De Clercq,et al.  Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors , 2019, Acta pharmaceutica Sinica. B.

[36]  Choongho Lee,et al.  Identification of novel non-nucleoside vinyl-stilbene analogs as potent norovirus replication inhibitors with a potential host-targeting mechanism. , 2019, European journal of medicinal chemistry.

[37]  M. Ajmal,et al.  Design, synthesis, in-silico study and anticancer potential of novel n-4- piperazinyl-ciprofloxacin-aniline hybrids. , 2019, Pakistan journal of pharmaceutical sciences.

[38]  P. Prathipati,et al.  A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study. , 2019, Antiviral research.

[39]  Sun-Young Chang,et al.  Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway , 2019, Scientific Reports.

[40]  M. Lanari,et al.  Impact of Rhinovirus Infections in Children , 2019, Viruses.

[41]  L. Svensson,et al.  Genetic Susceptibility to Human Norovirus Infection: An Update , 2019, Viruses.

[42]  Sana Aslam,et al.  An insight into the therapeutic potential of piperazine-based anticancer agents , 2019, TURKISH JOURNAL OF CHEMISTRY.

[43]  Peng Zhan,et al.  Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles. , 2019, Journal of medicinal chemistry.

[44]  R. Chung,et al.  Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus. , 2018, Methods in molecular biology.

[45]  N. Nayak,et al.  Synthesis and antiviral study of novel 4-(2-(6-amino-4-oxo-4,5-dihydro-1H-pyrrolo[2,3-d]pyrimidin-3-yl)ethyl)benzamide derivatives , 2018, Medicinal Chemistry Research.

[46]  E. De Clercq,et al.  Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine. , 2018, Bioorganic & medicinal chemistry letters.

[47]  D. V. Osipov,et al.  Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels. , 2018, European journal of medicinal chemistry.

[48]  E. A. Costa,et al.  Piperazine derivatives with central pharmacological activity used as therapeutic tools , 2018, Fundamental & clinical pharmacology.

[49]  I. Gilbert,et al.  Challenges and recent progress in drug discovery for tropical diseases , 2018, Nature.

[50]  R. Tandon,et al.  Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines. , 2018, Chemical record.

[51]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[52]  J. Deval,et al.  Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond , 2018, Antiviral Research.

[53]  Shanshan He,et al.  Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection , 2018, The Journal of infectious diseases.

[54]  O. Ramilo,et al.  Respiratory Syncytial Virus Seasonality: A Global Overview , 2018, The Journal of infectious diseases.

[55]  Afshan Kanwal,et al.  Benzimidazole Ring System as a Privileged Template for Anticancer Agents , 2018, Pharmaceutical Chemistry Journal.

[56]  E. Laurini,et al.  9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp). , 2018, Bioorganic & medicinal chemistry.

[57]  B. Selvakumar,et al.  Synthesis and antiviral study of 4-(7,7-dimethyl-4-(piperazin-1-yl)-5,6,7,8-tetrahydroquinazolin-2-yl) morpholine derivatives , 2018, Medicinal Chemistry Research.

[58]  Yunhao Wei,et al.  3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4. , 2018, Journal of medicinal chemistry.

[59]  A. Coluccia,et al.  Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study. , 2017, European journal of medicinal chemistry.

[60]  C. Wilke,et al.  Single-Cell Virology: On-Chip Investigation of Viral Infection Dynamics. , 2017, Cell reports.

[61]  Anh-Hoa Nguyen,et al.  Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. , 2017, Journal of hepatology.

[62]  C. Russell,et al.  The evolution of seasonal influenza viruses , 2017, Nature Reviews Microbiology.

[63]  R. Gottlieb,et al.  Coxsackievirus B Escapes the Infected Cell in Ejected Mitophagosomes , 2017, Journal of Virology.

[64]  A. Mansha,et al.  Antioxidant, antimicrobial and antiproliferative activities of peel and pulp extracts of red and white varieties of Ipomoea batatas (L) Lam , 2017 .

[65]  Ruiyuan Cao,et al.  Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. , 2017, Bioorganic & medicinal chemistry letters.

[66]  Z. Younossi.  Hepatitis C Infection: A Systemic Disease , 2017, Clinics in liver disease.

[67]  Y. Lucero,et al.  Norovirus vaccines under development. , 2017, Vaccine.

[68]  B. Selvakumar,et al.  Synthesis and antiviral activity of 4-(7,7-dimethyl-4-[4-{N-aroyl/benzyl}1-piperazinyl]-5,6,7,8-tetrahydroquinazolin-2-yl)morpholine derivatives , 2017 .

[69]  M. Ghany.  Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon. , 2017, Best practice & research. Clinical gastroenterology.

[70]  A. Mansha,et al.  Recent advancements in oxadiazole-based anticancer agents , 2017 .

[71]  Yong-tang Zheng,et al.  Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists. , 2017, European journal of medicinal chemistry.

[72]  N. Davis,et al.  Cytomegalovirus infection in pregnancy , 2017, Birth defects research.

[73]  Ketan A. Ganar,et al.  Avian Paramyxovirus: A Brief Review , 2017, Transboundary and emerging diseases.

[74]  Youwu Hao,et al.  Synthesis and antiviral evaluation of novel N-6 substituted adenosine analogues , 2017 .

[75]  A. Brancale,et al.  In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase. , 2017, European journal of medicinal chemistry.

[76]  A. Karimi,et al.  Anti-adenovirus activity, antioxidant potential, and phenolic content of black tea (Camellia sinensis Kuntze) extract , 2016, Journal of complementary & integrative medicine.

[77]  D. Z. Rechenchoski,et al.  Herpesvirus: an underestimated virus , 2016, Folia Microbiologica.

[78]  R. Loddo,et al.  Activity of bis(7-hydroxycoumarin) Mannich bases against bovine viral diarrhoea virus. , 2016, Antiviral research.

[79]  M. Manns,et al.  Future landscape of hepatitis C research - Basic, translational and clinical perspectives. , 2016, Journal of hepatology.

[80]  M. Roberge,et al.  Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel. , 2016, European journal of medicinal chemistry.

[81]  J. Dubuisson,et al.  Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus , 2016, Journal of Virology.

[82]  Guangdi Li,et al.  Approved Antiviral Drugs over the Past 50 Years , 2016, Clinical Microbiology Reviews.

[83]  J. Sánchez-Céspedes,et al.  New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships. , 2016, Journal of medicinal chemistry.

[84]  Han-Seung Shin,et al.  Piperazine derivatives for therapeutic use: a patent review (2010-present) , 2016, Expert opinion on therapeutic patents.

[85]  Yu Lin,et al.  New strategies against drug resistance to herpes simplex virus , 2016, International Journal of Oral Science.

[86]  L. Delang,et al.  The future of antivirals: broad-spectrum inhibitors , 2015, Current opinion in infectious diseases.

[87]  Y. Pommier,et al.  Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers. , 2015, European journal of medicinal chemistry.

[88]  Arvind H. Patel,et al.  Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents. , 2015, Bioorganic & medicinal chemistry letters.

[89]  D. Liotta,et al.  Discovery of novel N-aryl piperazine CXCR4 antagonists. , 2015, Bioorganic & medicinal chemistry letters.

[90]  G. Varani,et al.  Targeting Influenza A Virus RNA Promoter , 2015, Chemical biology & drug design.

[91]  A. Brancale,et al.  In silico structure-based design and synthesis of novel anti-RSV compounds. , 2015, Antiviral research.

[92]  V. Zarubaev,et al.  New carbocyclic N(6)-substituted adenine and pyrimidine nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, antiviral, anticancer activity and X-ray crystallography. , 2015, Bioorganic & medicinal chemistry.

[93]  R. Schinazi,et al.  Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazides , 2015, Medicinal Chemistry Research.

[94]  E. De Clercq,et al.  Design, Synthesis, and Anti‐HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding Pocket , 2015, Chemical biology & drug design.

[95]  S. Chander,et al.  Design, Synthesis, and Biological Evaluation of 1‐(thiophen‐2‐yl)‐9H‐pyrido[3,4‐b]indole Derivatives as Anti‐HIV‐1 Agents , 2015, Chemical biology & drug design.

[96]  Elena Bekerman,et al.  Combating emerging viral threats , 2015, Science.

[97]  Zonggen Peng,et al.  Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents , 2015, Acta pharmaceutica Sinica. B.

[98]  Xiaodong Ma,et al.  Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists. , 2015, Bioorganic & medicinal chemistry.

[99]  R. Ptak,et al.  Discovery and optimization of novel small-molecule HIV-1 entry inhibitors using field-based virtual screening and bioisosteric replacement. , 2014, Bioorganic & medicinal chemistry letters.

[100]  Landon R. Whitby,et al.  Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative. , 2014, Antiviral research.

[101]  T. Hermann,et al.  2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site. , 2014, Bioorganic & medicinal chemistry letters.

[102]  Jian-Ping Zuo,et al.  Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion. , 2014, Antiviral research.

[103]  S. Stramer.  Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections , 2014, ISBT science series.

[104]  K. Pedersen,et al.  Avian Paramyxovirus Serotype 1 (Newcastle Disease Virus), Avian Influenza Virus, and Salmonella spp. in Mute Swans (Cygnus olor) in the Great Lakes Region and Atlantic Coast of the United States , 2014, Avian diseases.

[105]  Mujahid Hussain Bukhari,et al.  Synthesis of novel pyrazolobenzothiazine 5,5-dioxide derivatives as potent anti-HIV-1 agents , 2014, Medicinal Chemistry Research.

[106]  Yuna Sun,et al.  Current progress in antiviral strategies , 2014, Trends in Pharmacological Sciences.

[107]  C. Tintori,et al.  The Fight against the Influenza A Virus H1N1: Synthesis, Molecular Modeling, and Biological Evaluation of Benzofurazan Derivatives as Viral RNA Polymerase Inhibitors , 2014, ChemMedChem.

[108]  C. N. Raju,et al.  New Urea and Thiourea Derivatives of Piperazine Doped with Febuxostat: Synthesis and Evaluation of Anti-TMV and Antimicrobial Activities , 2013, TheScientificWorldJournal.

[109]  Erik Serrao,et al.  Discovery of a novel 5-carbonyl-1H-imidazole-4-carboxamide class of inhibitors of the HIV-1 integrase-LEDGF/p75 interaction. , 2013, Bioorganic & medicinal chemistry.

[110]  C. Pannecouque,et al.  Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate‐Early 2 Protein, a Promising Target for Anti‐HCMV Treatment , 2013, ChemMedChem.

[111]  Junhai Xiao,et al.  Novel Substituted Heteroaromatic Piperazine and Piperidine Derivatives as Inhibitors of Human Enterovirus 71 and Coxsackievirus A16 , 2013, Molecules.

[112]  Robert P. Friedland,et al.  Humans Have Antibodies against a Plant Virus: Evidence from Tobacco Mosaic Virus , 2013, PloS one.

[113]  R. Ptak,et al.  Identification of a Small‐Molecule Inhibitor of HIV‐1 Assembly that Targets the Phosphatidylinositol (4,5)‐bisphosphate Binding Site of the HIV‐1 Matrix Protein , 2013, ChemMedChem.

[114]  R. Kao,et al.  Nucleozin Targets Cytoplasmic Trafficking of Viral Ribonucleoprotein-Rab11 Complexes in Influenza A Virus Infection , 2013, Journal of Virology.

[115]  J. Gardiner,et al.  Synthesis and antioxidant studies of novel N-substituted benzyl/phenyl-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl)acetamides , 2013, Medicinal Chemistry Research.

[116]  T. Liu,et al.  Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists , 2013, PloS one.

[117]  J. Heeres,et al.  Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents. , 2012, Bioorganic & medicinal chemistry letters.

[118]  M. Kukhanova,et al.  Synthesis and Anti‐HIV Properties of New Carbamate Prodrugs of AZT , 2012, Chemical biology & drug design.

[119]  M. Berg,et al.  Newcastle Disease Virus in Pakistan: Genetic Characterization and Implication in Molecular Diagnosis , 2012, Indian Journal of Virology.

[120]  T. Rana,et al.  Synthesis and Structure–Activity Relationship Studies of HIV‐1 Virion Infectivity Factor (Vif) Inhibitors that Block Viral Replication , 2012, ChemMedChem.

[121]  Mujahid Hussain Bukhari,et al.  Novel quinolyl-thienyl chalcones and their 2-pyrazoline derivatives with diverse substitution pattern as antileishmanial agents against Leishmania major , 2012, Medicinal Chemistry Research.

[122]  Hong Lu,et al.  Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors. , 2012, Bioorganic & medicinal chemistry letters.

[123]  S. Swindells,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2011, Journal of Family Planning and Reproductive Health Care.

[124]  Syed Umar Farooq Rizvi,et al.  Antioxidant and antimicrobial studies of novel N′-(substituted-2-chloroquinolin-3-yl)methylidene-4-hydroxy-2H-1,2-benzothiazine-3-carbohydrazides 1,1-dioxides , 2011, Medicinal Chemistry Research.

[125]  M. Otto,et al.  Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs. , 2011, Bioorganic & medicinal chemistry letters.

[126]  C. Pannecouque,et al.  Structural Investigation of the Naphthyridone Scaffold: Identification of a 1,6‐Naphthyridone Derivative with Potent and Selective Anti‐HIV Activity , 2011, ChemMedChem.

[127]  X. Zhang,et al.  Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[128]  C. Pannecouque,et al.  Studies of Anti‐HIV Transcription Inhibitor Quinolones: Identification of Potent N1‐Vinyl Derivatives , 2010, ChemMedChem.

[129]  M. Aytemir,et al.  A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities. , 2010, European journal of medicinal chemistry.

[130]  M. Bretner,et al.  Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication. , 2010, Bioorganic & medicinal chemistry.

[131]  N. Meanwell,et al.  Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity , 2009, Journal of medicinal chemistry.

[132]  E. De Clercq,et al.  Clinical features and treatment of adenovirus infections , 2008, Reviews in medical virology.

[133]  M. Echavarria.  Adenoviruses in Immunocompromised Hosts , 2008, Clinical Microbiology Reviews.

[134]  Soo-Yon Rhee,et al.  HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance , 2007, AIDS.

[135]  S. Bruce.  Febuxostat: A Selective Xanthine Oxidase Inhibitor for the Treatment of Hyperuricemia and Gout , 2006, The Annals of pharmacotherapy.

[136]  Thiam Hong Ang,et al.  Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents. , 2006, Antiviral research.

[137]  P. Yogeeswari,et al.  Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. , 2005, European journal of medicinal chemistry.

[138]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[139]  E. Clercq.  Antivirals and antiviral strategies , 2004, Nature Reviews Microbiology.

[140]  B. Neustadt,et al.  Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides. , 2003, Bioorganic & medicinal chemistry letters.

[141]  Elizabeth Connick,et al.  Antiretroviral-drug resistance among patients recently infected with HIV. , 2002, The New England journal of medicine.

[142]  B. Neustadt,et al.  Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist. , 2001, Journal of medicinal chemistry.

[143]  B. Song,et al.  Binding interactions between enantiomeric α-aminophosphonate derivatives and tobacco mosaic virus coat protein. , 2017, International journal of biological macromolecules.

[144]  Esther S. Kim,et al.  Letermovir: First Global Approval , 2017, Drugs.

[145]  N. Meanwell,et al.  Inhibitors of HIV-1 attachment. Part 7: indole-7-carboxamides as potent and orally bioavailable antiviral agents. , 2013, Bioorganic & medicinal chemistry letters.

[146]  L. Resnick,et al.  Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams. , 2000, Antiviral research.